Latest in Middlemen

Sort by

2 items

UnitedHealth fights back: Blame drugmakers for high costs, not the ‘middlemen.’

UnitedHealth Group’s stock sinks after profit beat expectations but revenue missed for the first time in more than four years.
MarketWatch - 5d
Top 3 drug insurers reaped billions as their drug middlemen inflated prices, FTC alleges

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.
NBC News - Jan. 14

UnitedHealth fights back: Blame drugmakers for high costs, not the ‘middlemen.’